Philip Morris International Inc. reports developments across its cigarette business and expanding smoke-free portfolio, including IQOS heated tobacco products, ZYN nicotine pouches and e-vapor offerings. Company news commonly covers quarterly results, shipment and revenue trends, product authorizations, brand collaborations, and updates tied to adult-smoker alternatives.
Recurring announcements also address U.S. and international regulatory matters, including FDA modified-risk tobacco product authorizations for IQOS, as well as annual shareholder meetings, board elections, executive compensation votes, auditor ratification, shareholder proposals, and corporate responsibility initiatives.
On May 11, 2022, Philip Morris Holland Holdings B.V. announced a public offer to acquire shares of Swedish Match AB. The acceptance period has been extended multiple times, with the latest deadline set for November 4, 2022. Regulatory approvals have been largely obtained, except for one from the European Commission, which is pending. As of October 3, 2022, shareholders have tendered approximately 0.51% of Swedish Match's shares. The merger aims to align with Philip Morris's strategy in a challenging market environment.
Summary not available.
The Framtiden Partnerships, a long-term shareholder of Swedish Match, opposed Philip Morris International's takeover bid of SEK 106 per share, deeming it undervalued. Framtiden estimates Swedish Match's intrinsic value at around SEK 200 per share, arguing the offer overlooks the company's growth potential in the non-tobacco nicotine market, particularly with its ZYN products. The Partnerships, owning approximately 1% of shares, expressed concerns that accepting the offer would force long-term investors to realize capital gains prematurely. They urge shareholders to reconsider the bid in light of Swedish Match's promising future.
Philip Morris International (PMI) is advocating for a world without cigarettes as the United Nations General Assembly convenes. The company has released a white paper titled Rethinking Disruption: Innovating for Better in an Era of Division, sharing insights from a survey of 17,207 adults across 14 countries. Key findings indicate widespread support for new technologies addressing health issues, particularly smoking. PMI emphasizes the importance of collaboration among stakeholders to enhance public health and promote smoke-free alternatives. Since 2008, PMI has invested over USD 9 billion in smoke-free product development, aiming to phase out cigarette sales.
The Board of Directors of Philip Morris International (NYSE: PM) has announced a 1.6% increase in its quarterly dividend, raising the annualized rate to $5.08 per share. The new quarterly dividend will be $1.27, effective October 12, 2022, for shareholders on record as of September 28, 2022. The ex-dividend date is September 27, 2022. PMI continues to innovate in the smoke-free sector, having invested over $9 billion in smoke-free products since 2008, aiming to shift its portfolio from traditional tobacco products.
Philip Morris International (PM) has appointed Dr. Badrul Chowdhury as Chief Life Sciences Officer and Dr. Matthew Holman as Vice President of U.S. Scientific Engagement and Regulatory Strategy. The appointments aim to enhance PM's science-based transformation towards a smoke-free future. Dr. Chowdhury, previously with the U.S. FDA and biotech sectors, brings extensive regulatory expertise. Dr. Holman, also ex-U.S. FDA, will strengthen PM's engagement with regulatory bodies. These strategic moves reflect PM's commitment to advancing innovative, smoke-free products.
Philip Morris International Inc. (NYSE: PM) CFO Emmanuel Babeau will present at the Barclays Global Consumer Staples Conference in Boston today at 1:30 p.m. ET. The event will be available via live webcast and on the PMI Investor Relations App. PMI is committed to delivering a smoke-free future, having invested over USD 9 billion since 2008 in smoke-free product development. By June 2022, approximately 13.2 million adults globally had switched to PMI's IQOS, which is marketed as a Modified Risk Tobacco Product by the FDA, available in 70 markets excluding Russia and Ukraine.
Philip Morris International (NYSE: PM) will host a live audio webcast featuring CFO Emmanuel Babeau at the Barclays Global Consumer Staples Conference on September 6, 2022, at 1:30 p.m. ET. The event can be accessed through PMI’s website or via their Investor Relations Mobile App. An archived copy will be available until October 5, 2022. PMI focuses on delivering a smoke-free future, having invested over USD 9 billion to innovate smoke-free products. As of June 30, 2022, PMI's products are available in 70 markets, with approximately 13.2 million adults having switched to IQOS.
On May 11, 2022, Philip Morris Holland Holdings B.V. (PMHH), an affiliate of Philip Morris International Inc. (PMI), announced a recommended public offer to Swedish Match AB shareholders to tender all shares. The acceptance period, initially expiring on September 30, 2022, is extended to October 21, 2022. PMHH has acquired necessary approvals, pending the European Commission's merger control approval. As of August 8, 2022, 3,637,683 shares (approx. 0.24% of voting rights) were tendered. Settlement is anticipated post-approval announcements, around October 27, 2022.
Philip Morris International reported a second-quarter diluted EPS of $1.43, with pro forma adjusted EPS of $1.32, indicating a 5.6% currency-neutral growth. The company announced a full-year EPS forecast of $5.73 to $5.88, showcasing a 10% to 12% anticipated growth. Despite challenges from the Ukraine conflict and disruptions in supply chains, total shipment volume rose by 3%, driven by a significant uptick in heated tobacco units. The firm plans to continue investment in smoke-free products, with pro forma revenues from these items constituting 30.5% of total revenue.